US Patent Issued to BRATTEA MedTech on July 28 for "Method for treating diabetes and nonalcoholic fatty liver disease, associated condition or disorder thereof, or symptoms thereof" (Chinese Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,279, issued on July 28, was assigned to BRATTEA MedTech Co. Ltd (Shanghai).

"Method for treating diabetes and nonalcoholic fatty liver disease, associated condition or disorder thereof, or symptoms thereof" was invented by Hongguang Cao (Shanghai), Haidong Chen (Shanghai), Jiulin Guo (Shanghai) and Meijun Shen (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a method for treating diabetes and nonalcoholic fatty liver disease (NAFLD), associated condition or disorder thereof, or symptoms thereof suffered by a subject such as a mammal (e.g. a human patient or a pet), comprising (1) placing one or more electrodes ...